BioGaia Makes Further Investment In MetaboGen

STOCKHOLM--(BUSINESS WIRE)--Regulatory News:

In December 2014 BioGaia (STO:BIOGB) reported its decision to invest SEK 12 million in MetaboGen AB, Gothenburg, Sweden. The investment should be made over a two year period.

The first investment of SEK 4 million took place in December 2014 and as MetaboGen has reached the agreed milestones the second investment of SEK 4 million was made today.

Back to news